The Global Burden of the Metabolic Syndrome and its Consequences for Diabetes and Cardiovascular Disease

The Metabolic Syndrome

Volumn , Issue , 2006, Pages 1-41

  Wild, Sarah H ^a   Byrne, Christopher D ^b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Diet and physical activity; Gene environment interactions; Global burden of metabolic syndrome; Hyperandrogenaemia and polycystic ovary syndrome (PCOS); Insulin resistance syndrome or syndrome X; Low birthweight and metabolic syndrome; Menopause and HRT; Metabolic syndrome and diabetes, CVD; Metabolic syndrome pathogenesis

Indexed keywords

EID: 84889851351     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/0470025131.ch1     Document Type: Chapter

References (147)

1. Aguilar-Salinas, C. A., Rojas, R., Gomez-Perez, F. J., Valles, V., Rios-Torres, J. M., Franco, A., Olaiz, G., Rull, J. A., Sepulveda, J. 2004. High prevalence of metabolic syndrome in Mexico. Arch. Med. Res., 35 (1), 76-81.
2. Al Lawati, J. A., Mohammed, A. J., Al Hinai, H. Q., Jousilahti, P. 2003. Prevalence of the metabolic syndrome among Omani adults. Diabetes Care, 26 (6), 1781-1785.
3. Alebiosu, C. O., Odusan, B. O. 2004. Metabolic syndrome in subjects with type-2 diabetes mellitus. J. Natl. Med. Assoc., 96 (6), 817-821.
4. Alexander, C. M., Landsman, P. B., Teutsch, S. M., Haffner, S. M. 2003. NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes, 52 (5), 1210-1214.
5. Aloia, J. F., Vaswani, A., Russo, L., Sheehan, M., Flaster, E. 1995. The influence of menopause and hormonal replacement therapy on body cell mass and body fat mass. Am. J. Obstet. Gynecol, 172 (3), 896-900.
6. Alvarez Leon, E. E., Ribas, B. L., Serra, M. L. 2003. [Prevalence of the metabolic syndrome in the population of Canary Islands, Spain]. Med. Clin. (Barcelona), 120 (5), 172-174.
7. Anand, S. S., Gerstein, H., Lonn, E., Jacobs, R., Vuksan, V., Teo, K., Davis, B., Montague, P., Yusuf, S. 2003. Relationship of metabolic syndrome and fibrinolytic dysfunction to cardiovascular disease. Circulation, 108 (4), 420-425.
8. Anderson, J. L., Horne, B. D., Jones, H. U., Reyna, S. P., Carlquist, J. F., Bair, T. L., Pearson, R. R., Lappe, D. L., Muhlestein, J. B. 2004. Which features of the metabolic syndrome predict the prevalence and clinical outcomes of angiographic coronary artery disease?. Cardiology, 101 (4), 185-193.
9. Azizi, F., Salehi, P., Etemadi, A., Zahedi-Asl, S. 2003. Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study. Diabetes Res. Clin. Pract., 61 (1), 29-37.
10. Balkau, B., Charles, M. A. 1999. Comment on the provisional report from the WHO Consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet. Med., 16 (5), 442-443.
11. Barbato, A., Cappuccio, F. P., Folkerd, E. J., Strazzullo, P., Sampson, B., Cook, D. G., Alberti, K. G. 2004. Metabolic syndrome and renal sodium handling in three ethnic groups living in England. Diabetologia, 47 (1), 40-46.
12. Barbazanges, A., Piazza, P. V., Le Moal, M., Maccari, S. 1996. Maternal glucocorticoid secretion mediates long-term effects of prenatal stress. J.Neurosci., 16 (12), 3943-3949.
13. Basu, R., Brar, J. S., Chengappa, K. N., John, V., Parepally, H., Gershon, S., Schlicht, P., Kupfer, D. J. 2004. The prevalence of the metabolic syndrome in patients with schizoaffective disorder-bipolar subtype. Bipolar Disord., 6 (4), 314-318.
14. Benediktsson, R., Lindsay, R. S., Noble, J., Seckl, J. R., Edwards, C. R. 1993. Glucocorticoid exposure in utero: new model for adult hypertension. Lancet, 341 (8841), 339-341.
15. Bjorntorp, P. 1995. Insulin resistance: the consequence of a neuroendocrine disturbance?. Int. J. Obes. Relat. Metab. Disord., 19 (Suppl. 1), S6-S10.
16. Bonora, E., Targher, G., Formentini, G., Calcaterra, F., Lombardi, S., Marini, F., Zenari, L., Saggiani, F., Poli, M., Perbellini, S., Raffaelli, A., Gemma, L., Santi, L., Bonadonna, R. C., Muggeo, M. 2004. The metabolic syndrome is an independent predictor of cardiovascular disease in type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study. Diabet. Med., 21 (1), 52-58.
17. Bruno, G., Merletti, F., Biggeri, A., Bargero, G., Ferrero, S., Runzo, C., Prina, C. S., Pagano, G., Cavallo-Perin, P. 2004. Metabolic syndrome as a predictor of all-cause and cardiovascular mortality in type 2 diabetes: the Casale Monferrato Study. Diabetes Care, 27 (11), 2689-2694.
18. Buemann, B., Vohl, M. C., Chagnon, M., Chagnon, Y. C., Gagnon, J., Perusse, L., Dionne, F., Despres, J. P., Tremblay, A., Nadeau, A., Bouchard, C. 1997. Abdominal visceral fat is associated with a BclI restriction fragment length polymorphism at the glucocorticoid receptor gene locus. Obes. Res., 5 (3), 186-192.
19. Byrne, C. D., Wild, S. H. 2000. Diabetes care needs evidence based interventions to reduce risk of vascular disease. BMJ, 320 (7249), 1554-1555.
20. Cameron, A. J., Shaw, J. E., Zimmet, P. Z. 2004. The metabolic syndrome: prevalence in world wide populations. Endocinol. Metab. Clin. North Am., 33, 351-375.
21. Cameron, A. J., Shaw, J. E., Zimmet, P. Z., Chitson, P., Alberti, K. G. 2003. Comparison of WHO and NCEP metabolic syndrome definitions over 5 years in Mauritius. Diabetologia, 46 (Suppl. 2), A3068.
22. Chandran, M., Phillips, S. A., Ciaraldi, T., Henry, R. R. 2003. Adiponectin: more than just another fat cell hormone? Diabetes Care, 26 (8), 2442-2450.
23. Chen, C. H., Lin, K. C., Tsai, S. T., Chou, P. 2000. Different association of hypertension and insulin-related metabolic syndrome between men and women in 8437 nondiabetic Chinese. Am. J. Hypertens., 13 (7), 846-853.
24. Collins, T., Cybulsky, M. I. 2001. NF-kappaB: pivotal mediator or innocent bystander in atherogenesis? J. Clin. Invest., 107 (3), 255-264.
25. Combs, T. P., Pajvani, U. B., Berg, A. H., Lin, Y., Jelicks, L. A., Laplante, M., Nawrocki, A. R., Rajala, M. W., Parlow, A. F., Cheeseboro, L., Ding, Y. Y., Russell, R. G., Lindemann, D., Hartley, A., Baker, G. R., Obici, S., Deshaies, Y., Ludgate, M., Rossetti, L., Scherer, P. E. 2004. A transgenic mouse with a deletion in the collagenous domain of adiponectin displays elevated circulating adiponectin and improved insulin sensitivity. Endocrinology, 145 (1), 367-383.
26. Cook, S., Weitzman, M., Auinger, P., Nguyen, M., Dietz, W. H. 2003. Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988-1994. Arch. Pediatr. Adolesc. Med., 157 (8), 821-827.
27. Corella, D., Ordovas, J. M. 2004. The metabolic syndrome: a crossroad for genotype-phenotype associations in atherosclerosis, Curr. Atheroscler. Rep., 6 (3), 186-196.
28. Costa, L. A., Canani, L. H., Lisboa, H. R., Tres, G. S., Gross, J. L. 2004. Aggregation of features of the metabolic syndrome is associated with increased prevalence of chronic complications in type 2 diabetes. Diabet. Med., 21 (3), 252-255.
29. Dallongeville, J., Cottel, D., Arveiler, D., Tauber, J. P., Bingham, A., Wagner, A., Fauvel, J., Ferrieres, J., Ducimetiere, P., Amouyel, P. 2004. The association of metabolic disorders with the metabolic syndrome is different in men and women. Ann. Nutr. Metab., 48 (1), 43-50.
30. Diez, J. J., Iglesias, P. 2003. The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur. J. Endocrinol., 148 (3), 293-300.
31. Edwards, C. R., Benediktsson, R., Lindsay, R. S., Seckl, J. R. 1993. Dysfunction of placental glucocorticoid barrier: link between fetal environment and adult hypertension?. Lancet, 341 (8841), 355-357.
32. Espeland, M. A., Stefanick, M. L., Kritz-Silverstein, D., Fineberg, S. E., Waclawiw, M. A., James, M. K., Greendale, G. A. 1997. Effect of postmenopausal hormone therapy on body weight and waist and hip girths. Postmenopausal Estrogen-Progestin Interventions Study Investigators. J. Clin. Endocrinol. Metab., 82 (5), 1549-1556.
33. Evans, E. M., Van Pelt, R. E., Binder, E. F., Williams, D. B., Ehsani, A. A., Kohrt, W. M. 2001. Effects of HRT and exercise training on insulin action, glucose tolerance, and body composition in older women. J. Appl. Physiol., 90 (6), 2033-2040.
34. Fain, J. N., Madan, A. K., Hiler, M. L., Cheema, P., Bahouth, S. W. 2004. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology, 145 (5), 2273-2282.
35. Farrell, S. W., Cheng, Y. J., Blair, S. N. 2004. Prevalence of the metabolic syndrome across cardiorespiratory fitness levels in women. Obes. Res., 12 (5), 824-830.
36. Filipovsky, J., Ducimetiere, P., Eschwege, E., Richard, J. L., Rosselin, G., Claude, J. R. 1996. The relationship of blood pressure with glucose, insulin, heart rate, free fatty acids and plasma cortisol levels according to degree of obesity in middle-aged men. J. Hypertens., 14 (2), 229-235.
37. Ford, E. S. 2004. The metabolic syndrome and mortality from cardiovascular disease and all-causes: findings from the National Health and Nutrition Examination Survey II Mortality Study. Atherosclerosis, 173 (2), 309-314.
38. Ford, E. S., Giles, W. H., Dietz, W. H. 2002. Prevalence of the metabolic syndrome among US adults from the Third National Health and Nutrition Examination Survey. JAMA, 287 (3), 356-359.
39. Fox, C. S., Coady, S., Sorlie, P. D., Levy, D., Meigs, J. B., D'Agostino, Sr, R. B., Wilson, P. W., Savage, P. J. 2004. Trends in cardiovascular complications of diabetes. JAMA, 292 (20), 2495-2499.
40. Gambacciani, M., Ciaponi, M., Cappagli, B., Piaggesi, L., De Simone, L., Orlandi, R., Genazzani, A. R. 1997. Body weight, body fat distribution, and hormonal replacement therapy in early postmenopausal women. J. Clin. Endocrinol. Metab., 82 (2), 414-417.
41. Gazzaruso, C., Sacchi, P., Garzaniti, A., Fratino, P., Bruno, R., Filice, G. 2002. Prevalence of metabolic syndrome among HIV patients. Diabetes Care, 25, 1253-1254.
42. Ghosh, S., Karin, M. 2002. Missing pieces in the NF-kappaB puzzle. Cell, 109 (Suppl.), S81-S96.
43. Gimeno Orna, J. A., Lou Arnal, L. M., Molinero, H. E., Boned, J. B., Portilla Cordoba, D. P. 2004. Metabolic syndrome as a cardiovascular risk factor in patients with type 2 diabetes. Rev. Esp. Cardiol., 57 (6), 507-513.
44. Girman, C. J., Rhodes, T., Mercuri, M., Pyorala, K., Kjekshus, J., Pedersen, T. R., Beere, P. A., Gotto, A. M., Clearfield, M. 2004. The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). Am. J. Cardiol., 93 (2), 136-141.
45. Goland, R. S., Jozak, S., Warren, W. B., Conwell, I. M., Stark, R. I., Tropper, P. J. 1993. Elevated levels of umbilical cord plasma corticotropin-releasing hormone in growth-retarded fetuses. J. Clin. Endocrinol. Metab., 77 (5), 1174-1179.
46. Goldstein, B. J., Scalia, R. 2004. Adiponectin: a novel adipokine linking adipocytes and vascular function. J. Clin. Endocrinol. Metab., 89 (6), 2563-2568.
47. Green, J. S., Stanforth, P. R., Rankinen, T., Leon, A. S., Rao, D. D., Skinner, J. S., Bouchard, C., Wilmore, J. H. 2004. The effects of exercise training on abdominal visceral fat, body composition, and indicators of the metabolic syndrome in postmenopausal women with and without estrogen replacement therapy: The HERITAGE Family Study. Metabolism, 53 (9), 1192-1196.
48. Grundy, S. M., Brewer, H. B., Jr. Cleeman, J. I., Smith, S. C., Jr., Lenfant, C. 2004. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation, 109 (3), 433-438.
49. Gupta, A., Gupta, R., Sarna, M., Rastogi, S., Gupta, V. P., Kothari, K. 2003. Prevalence of diabetes, impaired fasting glucose and insulin resistance syndrome in an urban Indian population. Diabetes Res. Clin. Pract., 61 (1), 69-76.
50. Haarbo, J., Marslew, U., Gotfredsen, A., Christiansen, C. 1991. Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause. Metabolism, 40 (12), 1323-1326.
51. Hales, C. N., Ozanne, S. E. 2003. For debate: fetal and early postnatal growth restriction lead to diabetes, the metabolic syndrome and renal failure. Diabetologia, 46 (7), 1013-1019.
52. Han, T. S., Sattar, N., Williams, K., Gonzalez-Villalpando, C., Lean, M. E., Haffner, S. M. 2002. Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study. Diabetes Care, 25 (11), 2016-2021.
53. Hanley, A. J., Festa, A., D'Agostino, R. B., Wagenknecht, L. E., Savage, P. J., Tracy, R. P., Saad, M. F., Haffner, S. M. 2004. Metabolic and inflammation variable clusters and prediction of type 2 diabetes: factor analysis using directly measured insulin sensitivity. Diabetes, 53 (7), 1773-1781.
54. Hautanen, A., Adlercreutz, H. 1993. Altered adrenocorticotropin and cortisol secretion in abdominal obesity: implications for the insulin resistance syndrome. J. Intern. Med., 234 (5), 461-469.
55. Hernandez, M. A., Riera, F. C., Martinez Triguero, M. L., Morillas, A. C., Cubells, C. P., Morales Suarez-Varela, M. 2004. Metabolic syndrome in patients with coronary heart disease. Results of using different diagnostic criteria. Rev. Esp. Cardiol., 57 (9), 889-893.
56. Ho, S. C., Chen, Y. M., Woo, J. L., Leung, S. S., Lam, T. H., Janus, E. D. 2001. Association between simple anthropometric indices and cardiovascular risk factors. Int. J. Obes. Relat. Metab. Disord, 25 (11), 1689-1697.
57. Holt, R. I., Peveler, R. C., Byrne, C. D. 2004. Schizophrenia, the metabolic syndrome and diabetes. Diabet. Med., 21 (6), 515-523.
58. Hu, G., Qiao, Q., Tuomilehto, J., Balkau, B., Borch-Johnsen, K., Pyorala, K. 2004. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Arch. Intern. Med., 164 (10), 1066-1076.
59. Ilanne-Parikka, P., Eriksson, J. G., Lindstrom, J., Hamalainen, H., Keinanen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Mannelin, M., Rastas, M., Salminen, V., Aunola, S., Sundvall, J., Valle, T., Lahtela, J., Uusitupa, M., Tuomilehto, J. 2004. Prevalence of the metabolic syndrome and its components: findings from a Finnish general population sample and the Diabetes Prevention Study cohort. Diabetes Care, 27 (9), 2135-2140.
60. Isomaa, B., Almgren, P., Tuomi, T., Forsen, B., Lahti, K., Nissen, M., Taskinen, M. R., Groop, L. 2001. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care, 24 (4), 683-689.
61. Jaber, L. A., Brown, M. B., Hammad, A., Zhu, Q., Herman, W. H. 2004. The prevalence of the metabolic syndrome among Arab americans. Diabetes Care, 27 (1), 234-238.
62. Jerico, C., Knobel, H., Montero, M., Ordonez-Llanos, J., Guelar, A., Gimeno, J. L., Saballs, P., Lopez-Colomes, J. L., Pedro-Botet, J. 2005. Metabolic syndrome among HIV-infected patients: prevalence, characteristics, and related factors. Diabetes Care, 28 (1), 132-137.
63. Jermendy, G., Hetyesi, K., Biro, L., Hidvegi, T. 2004. Prevalence of the metabolic syndrome in hypertensive and/or obese subjects. Diabet. Med., 21 (7), 805-806.
64. Jia, W. P., Xiang, K. S., Chen, L., Lu, J. X., Wu, Y. M. 2002. Epidemiological study on obesity and its comorbidities in urban Chinese older than 20 years of age in Shanghai, China. Obes. Rev, 3 (3), 157-165.
65. Kanaley, J. A., Sames, C., Swisher, L., Swick, A. G., Ploutz-Snyder, L. L., Steppan, C. M., Sagendorf, K. S., Feiglin, D., Jaynes, E. B., Meyer, R. A., Weinstock, R. S. 2001. Abdominal fat distribution in pre-and postmenopausal women: the impact of physical activity, age, and menopausal status. Metabolism, 50 (8), 976-982.
66. Kaplan, N. M. 1989. The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch. Intern. Med., 149 (7), 1514-1520.
67. Kato, M. M., Currier, M. B., Gomez, C. M., Hall, L., Gonzalez-Blanco, M. 2004. Prevalence of metabolic syndrome in Hispanic and non-Hispanic patients With schizophrenia. Prim. Care Compan. J. Clin. Psychiatry, 6 (2), 74-77.
68. Kenyon, C. J., Panarelli, M., Zagato, L., Torielli, L., Heeley, R. P., Holloway, C. D., Fraser, R., Casari, G., Sutcliffe, R. G., Bianchi, G. 1998. Glucocorticoid receptor polymorphism in genetic hypertension. J. Mol. Endocrinol., 21 (1), 41-50.
69. Kim, M. H., Kim, M. K., Choi, B. Y., Shin, Y. J. 2004. Prevalence of the metabolic syndrome and its association with cardiovascular diseases in Korea. J. Korean Med. Sci., 19 (2), 195-201.
70. Kinlaw, W. B., Marsh, B. 2004. Adiponectin and HIV-lipodystrophy: taking HAART. Endocrinology, 145 (2), 484-486.
71. Kritz-Silverstein, D., Barrett-Connor, E. 1996. Long-term postmenopausal hormone use, obesity, and fat distribution in older women. JAMA, 275 (1), 46-49.
72. Kubota, N., Terauchi, Y., Yamauchi, T., Kubota, T., Moroi, M., Matsui, J., Eto, K., Yamashita, T., Kamon, J., Satoh, H., Yano, W., Froguel, P., Nagai, R., Kimura, S., Kadowaki, T., Noda, T. 2002. Disruption of adiponectin causes insulin resistance and neointimal formation. J. Biol. Chem, 277 (29), 25863-25866.
73. Laaksonen, D. E., Lakka, H. M., Niskanen, L. K., Kaplan, G. A., Salonen, J. T., Lakka, T. A. 2002. Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. Am. J. Epidemiol., 156 (11), 1070-1077.
74. Laaksonen, D. E., Niskanen, L., Punnonen, K., Nyyssonen, K., Tuomainen, T. P., Valkonen, V. P., Salonen, R., Salonen, J. T. 2004. Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men. Diabetes Care, 27 (5), 1036-1041.
75. Lakka, H. M., Laaksonen, D. E., Lakka, T. A., Niskanen, L. K., Kumpusalo, E., Tuomilehto, J., Salonen, J. T. 2002. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA, 288 (21), 2709-2716.
76. Langley-Evans, S. C. 1997. Intrauterine programming of hypertension by glucocorticoids. Life Sci., 60 (15), 1213-1221.
77. Lee, W. Y., Park, J. S., Noh, S. Y., Rhee, E. J., Kim, S. W., Zimmet, P. Z. 2004. Prevalence of the metabolic syndrome among 40,698 Korean metropolitan subjects. Diabetes Res. Clin. Pract, 65 (2), 143-149.
78. Levitt, N. S., Lindsay, R. S., Holmes, M. C., Seckl, J. R. 1996. Dexamethasone in the last week of pregnancy attenuates hippocampal glucocorticoid receptor gene expression and elevates blood pressure in the adult offspring in the rat. Neuroendocrinology, 64 (6), 412-418.
79. Li, Q., Verma, I. M. 2002. NF-kappaB regulation in the immune system. Nat. Rev. Immunol., 2 (10), 725-734.
80. Lindsay, R. S., Lindsay, R. M., Edwards, C. R., Seckl, J. R. 1996. Inhibition of 11-beta-hydroxysteroid dehydrogenase in pregnant rats and the programming of blood pressure in the offspring. Hypertension, 27 (6), 1200-1204.
81. Lorenzo, C., Okoloise, M., Williams, K., Stern, M. P., Haffner, S. M. 2003. The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study. Diabetes Care, 26 (11), 3153-3159.
82. Maeda, N., Shimomura, I., Kishida, K., Nishizawa, H., Matsuda, M., Nagaretani, H., Furuyama, N., Kondo, H., Takahashi, M., Arita, Y., Komuro, R., Ouchi, N., Kihara, S., Tochino, Y., Okutomi, K., Horie, M., Takeda, S., Aoyama, T., Funahashi, T., Matsuzawa, Y. 2002. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat. Med., 8 (7), 731-737.
83. Malik, S., Wong, N. D., Franklin, S. S., Kamath, T. V., L'Italien, G. J., Pio, J. R., Williams, G. R. 2004. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation, 110 (10), 1240-1245.
84. Marchesini, G., Forlani, G., Cerrelli, F., Manini, R., Natale, S., Baraldi, L., Ermini, G., Savorani, G., Zocchi, D., Melchionda, N. 2004. WHO and ATPIII proposals for the definition of the metabolic syndrome in patients with Type 2 diabetes. Diabet. Med., 21 (4), 383-387.
85. Marin, P., Arver, S. 1998. Androgens and abdominal obesity. Baillieres Clin. Endocrinol. Metab, 12 (3), 441-451.
86. Marin, P., Darin, N., Ameniya, T., Andersson, B., Jern, S., Bjorntorp, P. 1992. Cortisol secretion in relation to body fat distribution in obese premenopausal women. Metabolism, 41 (8), 882-886.
87. McCaffery, J. M., Niaura, R., Todaro, J. F., Swan G. E., Carmelli, D. 2003. Depressive symptoms and metabolic risk in adult male twins enrolled in the National Heart, Lung, and Blood Institute twin study. Psychosom. Med., 65 (3), 490-497.
88. McKeown, N. M., Meigs, J. B., Liu, S., Saltzman, E., Wilson, P. W., Jacques, P. F. 2004. Carbohydrate nutrition, insulin resistance, and the prevalence of the metabolic syndrome in the Framingham Offspring Cohort. Diabetes Care, 27 (2), 538-546.
89. McNeill, A. M., Rosamond, W. D., Girman, C. J., Golden, S. H., Schmidt, M. I., East, H. E., Ballantyne, C. M., Heiss, G. 2005. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care, 28 (2), 385-390.
90. Meigs, J. B., Wilson, P. W., Nathan, D. M., D'Agostino, Sr, R. B., Williams, K., Haffner, S. M. 2003. Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies. Diabetes, 52 (8), 2160-2167.
91. Nakanishi, N., Takatorige, T., Fukuda, H., Shirai, K., Li, W., Okamoto, M., Yoshida, H., Matsuo, Y., Suzuki, K., Tatara, K. 2004. Components of the metabolic syndrome as predictors of cardiovascular disease and type 2 diabetes in middle-aged Japanese men. Diabetes Res. Clin. Pract., 64, 59-70.
92. Naray-Fejes-Toth, A., Colombowala, I. K., Fejes-Toth, G. 1998. The role of 11β-hydroxys-teroid dehydrogenase in steroid hormone specificity. J. Steroid Biochem. Mol. Biol., 65 (1-6), 311-316.
93. NCEP Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults, 2001. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA, 285 (19), 2486-2497.
94. Nesto, R. 2004. C-Reactive protein, its role in inflammation, Type 2 diabetes and cardiovascular disease, and the effects of insulin-sensitizing treatment with thiazolidinediones. Diabet. Med, 21 (8), 810-817.
95. Oh, J. Y., Hong, Y. S., Sung, Y. A., Barrett-Connor, E. 2004. Prevalence and factor analysis of metabolic syndrome in an urban Korean population. Diabetes Care, 27 (8), 2027-2032.
96. Onat, A., Ceyhan, K., Basar, O., Erer, B., Toprak, S., Sansoy, V. 2002. Metabolic syndrome: major impact on coronary risk in a population with low cholesterol levels-a prospective and cross-sectional evaluation. Atherosclerosis, 165 (2), 285-292.
97. Ozsahin, A. K., Gokcel, A., Sezgin, N., Akbaba, M., Guvener, N., Ozisik, L., Karademir, B. M. 2004. Prevalence of the metabolic syndrome in a Turkish adult population. Diabetes Nutr. Metab, 17 (4), 230-234.
98. Panagiotakos, D. B., Pitsavos, C., Chrysohoou, C., Skoumas, J., Tousoulis, D., Toutouza, M., Toutouzas, P., Stefanadis, C. 2004. Impact of lifestyle habits on the prevalence of the metabolic syndrome among Greek adults from the ATTICA study. Am. Heart, J., 147 (1), 106-112.
99. Panarelli, M., Holloway, C. D., Fraser, R., Connell, J. M., Ingram, M. C., Anderson, N. H., Kenyon, C. J. 1998. Glucocorticoid receptor polymorphism, skin vasoconstriction, and other metabolic intermediate phenotypes in normal human subjects. J. Clin. Endocrinol. Metab, 83 (6), 1846-1852.
100. Pasquali, R., Cantobelli, S., Casimirri, F., Capelli, M., Bortoluzzi, L., Flamia, R., Labate, A. M., Barbara, L. 1993. The hypothalamic-pituitary-adrenal axis in obese women with different patterns of body fat distribution. J. Clin. Endocrinol. Metab., 77 (2), 341-346.
101. Phillips, D. I., Barker, D. J., Fall, C. H., Seckl, J. R., Whorwood, C. B., Wood, P. J., Walker, B. R. 1998. Elevated plasma cortisol concentrations: a link between low birth weight and the insulin resistance syndrome?. J. Clin. Endocrinol. Metab., 83 (3), 757-760.
102. Poehlman, E. T., Tchernof, A. 1998. Traversing the menopause: changes in energy expenditure and body composition. Coron.Artery Dis., 9 (12), 799-803.
103. Poulsen, P., Vaag, A., Kyvik, K., Beck-Nielsen, H. 2001. Genetic versus environmental aetiology of the metabolic syndrome among male and female twins. Diabetologia, 44 (5), 537-543.
104. Ramachandran, A., Snehalatha, C., Satyavani, K., Sivasankari, S., Vijay, V. 2003. Metabolic syndrome in urban Asian Indian adults-a population study using modified ATP III criteria. Diabetes Res. Clin. Pract., 60 (3), 199-204.
105. Reaven, G. M. 1988. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes, 37 (12), 1595-1607.
106. Relimpio, F., Martinez-Brocca, M. A., Leal-Cerro, A., Losada, F., Mangas, M. A., Pumar, A., Astorga, R. 2004. Variability in the presence of the metabolic syndrome in Type 2 diabetic patients attending a diabetes clinic; influences of age and gender. Diabetes Res. Clin. Pract, 65 (2), 135-142.
107. Rennie, K. L., McCarthy, N., Yazdgerdi, S., Marmot, M., Brunner, E. 2003. Association of the metabolic syndrome with both vigorous and moderate physical activity. Int. J. Epidemiol., 32 (4), 600-606.
108. Reubinoff, B. E., Wurtman, J., Rojansky, N., Adler, D., Stein, P., Schenker, J. G., Brzezinski, A. 1995. Effects of hormone replacement therapy on weight, body composition, fat distribution, and food intake in early postmenopausal women: a prospective study. Fertil. Steril., 64 (5), 963-968.
109. Reul, J. M., Stec, I., Wiegers, G. J., Labeur, M. S., Linthorst, A. C., Arzt, E., Holsboer, F. 1994. Prenatal immune challenge alters the hypothalamic-pituitary-adrenocortical axis in adult rats. J. Clin. Invest., 93 (6), 2600-2607.
110. Rguibi, M., Belahsen, R. 2004. Metabolic syndrome among Moroccan Sahraoui adult women. Am. J. Hum. Biol., 16 (5), 598.
111. Ridker, P. M., Buring, J. E., Cook, N. R., Rifai, N. 2003. C-Reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation, 107 (3), 391-397.
112. Rosell, M., De Faire, U., Hellenius, M. L. 2003. Low prevalence of the metabolic syndrome in wine drinkers-is it the alcohol beverage or the lifestyle? Eur. J. Clin. Nutr., 57 (2), 227-234.
113. Rosmond, R., Dallman, M. F., Bjorntorp, P. 1998. Stress-related cortisol secretion in men: relationships with abdominal obesity and endocrine, metabolic and hemodynamic abnormalities. J. Clin. Endocrinol. Metab., 83 (6), 1853-1859.
114. Ryan, A. S., Nicklas, B. J., Berman, D. M. 2002. Hormone replacement therapy, insulin sensitivity, and abdominal obesity in postmenopausal women. Diabetes Care, 25 (1), 127-133.
115. Santos, A. C., Lopes, C., Barros, H. 2004. Prevalence of metabolic syndrome in the city of Porto. Rev. Port. Cardiol., 23 (1), 45-52.
116. Sattar, N., Gaw, A., Scherbakova, O., Ford, I., O'Reilly, D. S., Haffner, S. M., Isles, C., Macfarlane, P. W., Packard, C. J., Cobbe, S. M., Shepherd, J. 2003. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation, 108 (4), 414-419.
117. Seckl, J. R. 1994. Glucocorticoids and small babies. Q. J. Med., 87 (5), 259-262.
118. Seckl, J. R., & Walker, B. R. 2004. 11β-Hydroxy steroid dehydrogenase type 1 as a modulator of glucocorticoid action: from metabolism to memory. Trends Endocrinol. Metab, 15 (9), 418-424.
119. Sites, C. K., Brochu, M., Tchernof, A., Poehlman, E. T. 2001. Relationship between hormone replacement therapy use with body fat distribution and insulin sensitivity in obese postmenopausal women. Metabolism, 50 (7), 835-840.
120. St Onge, M. P., Janssen, I., Heymsfield, S. B. 2004. Metabolic syndrome in normal-weight Americans: new definition of the metabolically obese, normal-weight individual. Diabetes Care, 27 (9), 2222-2228.
121. Stolk, R. P., Lamberts, S. W., de Jong, F. H., Pols, H. A., Grobbee, D. E. 1996. Gender differences in the associations between cortisol and insulin in healthy subjects. J. Endocrinol., 149 (2), 313-318.
122. Sung, R. Y., Tong, P. C., Yu, C. W., Lau, P. W., Mok, G. T., Yam, M. C., Lam, P. K., Chan, J. C. 2003. High prevalence of insulin resistance and metabolic syndrome in overweight/obese preadolescent Hong Kong Chinese children aged 9-12 years. Diabetes Care, 26 (1), 250-251.
123. Tanchoco, C. C., Cruz, A. J., Duante, C. A., Litonjua, A. D. 2003. Prevalence of metabolic syndrome among Filipino adults aged 20 years and over. Asia Pac. J. Clin. Nutr., 12 (3), 271-276.
124. Tangalakis, K., Lumbers, E. R., Moritz, K. M., Towstoless, M. K., Wintour, E. M. 1992. Effect of cortisol on blood pressure and vascular reactivity in the ovine fetus. Exp. Physiol, 77 (5), 709-717.
125. Tchernof, A., Calles-Escandon, J., Sites, C. K., Poehlman, E. T. 1998. Menopause, central body fatness, and insulin resistance: effects of hormone-replacement therapy. Coron. Artery Dis., 9 (8), 503-511.
126. Temelkova-Kurktschiev, T., Siegert, G., Bergmann, S., Henkel, E., Koehler, C., Jaross, W., Hanefeld, M. 2002. Subclinical inflammation is strongly related to insulin resistance but not to impaired insulin secretion in a high risk population for diabetes. Metabolism, 51 (6), 743-749.
127. Vernay, M., Balkau, B., Moreau, J. G., Sigalas, J., Chesnier, M. C., Ducimetiere, P. 2004. Alcohol consumption and insulin resistance syndrome parameters: associations and evolutions in a longitudinal analysis of the French DESIR cohort. Ann. Epidemiol., 14 (3), 209-214.
128. Villegas, R., Perry, I. J., Creagh, D., Hinchion, R., O'Halloran, D. 2003. Prevalence of the metabolic syndrome in middle-aged men and women. Diabetes Care, 26 (11), 3198-3199.
129. Vozarova de Court, de Court, Hanson, R. L., Zahorakova, A., Egyenes, H. P., Tataranni, P. A., Bennett, P. H., Vozar, J. 2003. Higher prevalence of type 2 diabetes, metabolic syndrome and cardiovascular diseases in Gypsies than in non-Gypsies in Slovakia. Diabetes Res. Clin. Pract, 62 (2), 95-103.
130. Walker, B. R., Phillips, D. I., Noon, J. P., Panarelli, M., Andrew, R., Edwards, H. V., Holton, D. W., Seckl, J. R., Webb, D. J., Watt, G. C. 1998. Increased glucocorticoid activity in men with cardiovascular risk factors. Hypertension, 31 (4), 891-895.
131. Wang, M. 2005. The role of glucocorticoid action in the pathophysiology of the Metabolic Syndrome. Nutr. Metab., 2 (1), 3.
132. Weaver, J. U., Hitman, G. A., Kopelman, P. G. 1992. An association between a Bc11 restriction fragment length polymorphism of the glucocorticoid receptor locus and hyper-insulinaemia in obese women. J. Mol. Endocrinol., 9 (3), 295-300.
133. Weiss, R., Dziura, J., Burgert, T. S., Tamborlane, W. V., Taksali, S. E., Yeckel, C. W., Allen, K., Lopes, M., Savoye, M., Morrison, J., Sherwin, R. S., Caprio, S. 2004. Obesity and the metabolic syndrome in children and adolescents. N. Engl. J. Med., 350 (23), 2362-2374.
134. White, P. C., Mune, T., Agarwal, A. K. 1997. 11 β-Hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess. Endocr.Rev., 18 (1), 135-156.
135. WHO Consultation 1999.Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications, Part 1: Diagnosis and Classification of Diabetes Mellitus. World Health Organization: Geneva.
136. WHO Expert Consultation 2004. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet, 363, (9403), 157-163.
137. Whorwood, C. B., Ricketts, M. L., Stewart, P. M. 1994. Epithelial cell localization of type 2 11 β-hydroxysteroid dehydrogenase in rat and human colon. Endocrinology, 135 (6), 2533-2541.
138. Whorwood, C. B., Mason, J. I., Ricketts, M. L., Howie, A. J., Stewart, P. M. 1995. Detection of human 11β-hydroxysteroid dehydrogenase isoforms using re verse-transcrip tase-polymerase chain reaction and localization of the type 2 isoform to renal collecting ducts. Mol. Cell Endocrinol, 110 (1-2), R7-R12.
139. Whorwood, C. B., Donovan, S. J., Flanagan, D., Phillips, D. I., Byrne, C. D. 2002. Increased glucocorticoid receptor expression in human skeletal muscle cells may contribute to the pathogenesis of the metabolic syndrome. Diabetes, 51 (4), 1066-1075.
140. Wild, S. H., Roglic, G., Green, A., Sicree, R., King, H. 2004. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care, 27, 1047-1053.
141. Wu, G. X., Wu, Z. S., Liu, J., Wang, W., Zhao, D., Hou, L., Zeng, Z. C., Wang, W. H., Liu, J., Qin, L. P., Liu, S. 2002. [The prevalence of metabolic syndrome in a 11 provinces cohort in China]. Zhonghua Yu Fang Yi. Xue. Za Zhi., 36 (5), 298-300.
142. Yamauchi, T., Kamon, J., Ito, Y., Tsuchida, A., Yokomizo, T., Kita, S., Sugiyama, T., Miyagishi, M., Hara, K., Tsunoda, M., Murakami, K., Ohteki, T., Uchida, S., Takekawa, S., Waki, H., Tsuno, N. H., Shibata, Y., Terauchi, Y., Froguel, P., Tobe, K., Koyasu, S., Taira, K., Kitamura, T., Shimizu, T., Nagai, R., Kadowaki, T. 2003. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature, 423 (6941), 762-769.
143. Yarbrough, D. E., Barrett-Connor, E., Kritz-Silverstein, D., Wingard, D. L. 1998. Birth weight, adult weight, and girth as predictors of the metabolic syndrome in postmenopausal women: the Rancho Bernardo Study. Diabetes Care, 21 (10), 1652-1658.
144. Yoon, Y. S., Oh, S. W., Baik, H. W., Park, H. S., Kim, W. Y. 2004. Alcohol consumption and the metabolic syndrome in Korean adults: the 1998 Korean National Health and Nutrition Examination Survey. Am. J. Clin. Nutr., 80 (1), 217-224.
145. Zhang, J., Byrne, C. D. 1997. A novel highly reproducible quantitative competitve RT PCR system. J. Mol. Biol., 274 (3), 338-352.
146. Zhang, J., Byrne, C. D. 1999. Differential priming of RNA templates during cDNA synthesis markedly affects both accuracy and reproducibility of quantitative competitive reverse-transcriptase PCR. Biochem. J., 337 (2), 231-241.
147. Zhang, J., Desai, M., Ozanne, S. E., Doherty, C., Hales, C. N., Byrne, C. D. 1997. Two variants of quantitative reverse transcriptase PCR used to show differential expression of alpha-, beta-and gamma-fibrinogen genes in rat liver lobes. Biochem. J., 321 (3), 769-775.